Cite
HARVARD Citation
Martin-babau, J. et al. (n.d.). 1320 Eribulin mesylate in metastatic breast cancer, a focus on safety and efficacy in elderly patients. Results from the EVHALAVEN multicentric retrospective cohort. European journal of cancer. pp. S193-S194. [Online].